As a critical presidential election in the US draws nearer, the Investing News Network asked two fund managers to share their perspectives on the cannabis investment landscape.
The guests were Nawan Butt, portfolio manager at Purpose Investments and co-manager of the Purpose Marijuana Opportunities Fund (NEO:MJJ), and Dan Ahrens, managing director and chief operating officer with AdvisorShares and manager of the AdvisorShares Pure Cannabis ETF (ARCA:YOLO).
To stay ahead and keep their funds performing well, both of the fund managers carefully scan developments in the cannabis market on a day-to-day basis.
Ahrens kicked the discussion off by noting that he is still supremely interested in seeing healthy balance sheets and in tracking the path to profitability for cannabis companies. He is excited about the rising division between players that are performing well and those that aren’t.
“Cannabis stocks have traded way too much on hype in the past,” Ahrens said. “In 2020, we’re seeing some real separation between some of the biggest Canadian licensed producers.”
AdvisorShares recently launched a new cannabis exchange-traded fund (ETF) focused entirely on multi-state operators in the US market. It is called the AdvisorShares Pure US Cannabis ETF (ARCA:MSOS) and is also managed by Ahrens.
Ahrens previously shared his frustration with the cannabis investment space, particularly in terms of the lack of awareness on which companies will actually benefit from advancements in the US — a market he is heavily bullish on when it comes to cannabis.
Six month performance of the AdvisorShares Pure Cannabis ETF.
Ahrens and Butt both share the view that the US market represents the smart money opportunity for investors at the moment, offering a clear distinction in the overall cannabis stock universe.
Beyond the presidential election, the American cannabis market is set to potentially see some catalysts as five states in the country ask voters about introducing cannabis programs. Decisions are pending in Arizona, Mississippi, Montana, New Jersey and South Dakota, and could add momentum for operators.
Butt pointed to New Jersey as a state market that he is watching in particular. Additionally, he praised Arizona as a state with an organized framework with its medical cannabis program and said he is excited by the potential of this market going recreational this year.
Six month performance of the Purpose Marijuana Opportunities Fund.
In a recent note to investors, Butt, alongside Greg Taylor, his fellow fund manager and the chief investment officer at Purpose Investments, wrote that the upswing for cannabis operations in US state markets will continue with or without federal reform for the industry.
“We continue to see outsized growth in most states as operators have worked out how to optimize within the current constraints,” the pair from Purpose Investments wrote as part of their commentary. “Any reform at the federal level will cause a step function in valuations of these operators, but explosive growth can still continue under current regulations.”
Watch the full video above to hear the entire discussion between Butt and Ahrens.
Don’t forget to follow us @INN_Cannabis for real-time updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.
Meanwhile, two longstanding cannabis partners ended their relationship.
Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development
Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.
The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 with Planned Completion and Emergency Use Authorization Request
Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.
With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.
HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.
DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.